Jetzone Jet Lag Prevention Tablet, Chewable
NDC Package 63923-100-30
Package Information
Jetzone Jet Lag Prevention (arnica montana, anamirta cocculus, potassium phosphate, gelsemium sempervirens, strychnos nux vomica, silver nitrate) tablets is directionsFor Adults and Children over 6 years: Chew one tablet, up to one hour prior to every takeoff.Chew one ta blet approximately every 2 hours and one within 1 hour of each landing. This formulation utilizes a tablet, chewable delivery system. Marketed by Belclare Corporation, this product is identified by NDC 63923-100.
Identification & Billing
Clinical Specifications
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Potassium Compounds - [CS]
- Potassium Salt - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 63923 - Belclare Corporation
- 63923-100 - Jetzone Jet Lag Prevention
- 63923-100-30 - 2 BLISTER PACK in 1 CARTON / 15 TABLET, CHEWABLE in 1 BLISTER PACK
- 63923-100 - Jetzone Jet Lag Prevention
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 63923-100-30 identifies a specific commercial package of 2 blister pack in 1 carton / 15 tablet, chewable in 1 blister pack of Jetzone Jet Lag Prevention, a human over the counter drug labeled by Belclare Corporation. This tablet, chewable is formulated for oral use and contains anamirta cocculus seed; arnica montana; gelsemium sempervirens root; potassium phosphate, dibasic; silver nitrate; strychnos nux-vomica whole as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Belclare Corporation on January 01, 2008. The current certification is valid through December 31, 2026.
How is this Belclare Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 63923010030. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.